Ingenix Enhances Outcomes Services
Eden Prairie, Minn.-based Ingenix, the health information technology unit of UnitedHealth Group, has acquired QualityMetric Inc., a health outcomes measurement vendor. Terms of the acquisition were not disclosed.
Eden Prairie, Minn.-based Ingenix, the health information technology unit of UnitedHealth Group, has acquired QualityMetric Inc., a health outcomes measurement vendor. Terms of the acquisition were not disclosed.
Lincoln, R.I.-based QualityMetric develops patient-reported outcomes surveys to measure the effectiveness of multiple programs, and software to analyze and score results. These programs include clinical trials, disease management, clinical improvement, pharmaceutical marketing, risk prediction, population monitoring and patient satisfaction, among others.
QualityMetric's surveys have been used in thousands of clinical trials and cited in more than 14,000 peer-reviewed articles, according to the companies. The acquisition will complement the work of Ingenix's Lewin Group Center for Comparative Effectiveness Research. The buy also will expand Ingenix's services to the life sciences, government, health system, insurer and consumer markets.
The American Recovery and Reinvestment Act appropriated $1.1 billion for comparative effectiveness research to assess the strengths and weaknesses of various medical treatments. More information on QualityMetric is available at qualitymetric.com.
--Joseph Goedert
Lincoln, R.I.-based QualityMetric develops patient-reported outcomes surveys to measure the effectiveness of multiple programs, and software to analyze and score results. These programs include clinical trials, disease management, clinical improvement, pharmaceutical marketing, risk prediction, population monitoring and patient satisfaction, among others.
QualityMetric's surveys have been used in thousands of clinical trials and cited in more than 14,000 peer-reviewed articles, according to the companies. The acquisition will complement the work of Ingenix's Lewin Group Center for Comparative Effectiveness Research. The buy also will expand Ingenix's services to the life sciences, government, health system, insurer and consumer markets.
The American Recovery and Reinvestment Act appropriated $1.1 billion for comparative effectiveness research to assess the strengths and weaknesses of various medical treatments. More information on QualityMetric is available at qualitymetric.com.
--Joseph Goedert
More for you
Loading data for hdm_tax_topic #better-outcomes...